Esorubicin in advanced ovarian epithelial cancer. A phase II study of the EORTC Gynecological Cancer Cooperative Group.
van Oosterom
A T
AT
Department of Clinical Oncology, University Hospital, Leiden, The Netherlands.
Aapro
M S
MS
Carnino
F
F
van der Burg
M E
ME
Pecorelli
S
S
Rotmensz
N
N
Dalesio
O
O
Vermorken
J B
JB
D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D004317:Doxorubicin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy*
D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin; C030851:esorubicin